Globeimmune Net Cash Flow 2013-2016 | GBIM

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Globeimmune net cash flow from 2013 to 2016. Net cash flow can be defined as the total change in cash for the company over the given period.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Globeimmune net cash flow from 2013 to 2016. Net cash flow can be defined as the total change in cash for the company over the given period.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$20.8B
Dr Reddy's Laboratories (RDY)	$11.9B
BridgeBio Pharma (BBIO)	$9.3B
Bausch Health Cos (BHC)	$2.7B
Supernus Pharmaceuticals (SUPN)	$2.5B
Amphastar Pharmaceuticals (AMPH)	$1.4B
Taysha Gene Therapies (TSHA)	$807M
Personalis (PSNL)	$433M
Assembly Biosciences (ASMB)	$197M
Sol-Gel Technologies (SLGL)	$65M
Evoke Pharma (EVOK)	$8M
Teligent (TLGT)	$0M